Details for Patent: 4,529,596
✉ Email this page to a colleague
Summary for Patent: 4,529,596
| Title: | Thieno [3,2-c] pyridine derivatives and their therapeutic application |
| Abstract: | This invention relates to new thieno [3,2-c] pyridine derivatives having the formula: ##STR1## in which: Y represents the OH group or an OR group in which R is a straight or branched lower alkyl radical, or Y represents a group ##STR2## in which R.sub.1 and R.sub.2 are each independently of each other, hydrogen or a straight or branched lower alkyl group; or R.sub.1 and R.sub.2 form together and with the nitrogen atom to which they are attached a heterocycle which may include a second heteroatom such as oxygen or nitrogen, wherein the latter may be substituted by a lower alkyl or benzyl radical which may be substituted; and X represents hydrogen, a halogen or a lower alkyl radical; and their addition salts with pharmaceutically acceptable mineral or organic acids if Y represents the group OR or ##STR3## or with mineral bases if Y represents OH, as well as the two enantiomers or their mixture. The invention also relates to the preparation process of new thieno [3,2-c] pyridine derivatives and to their therapeutic application as blood-platelet aggregation inhibiting agents and antithrombotics. |
| Inventor(s): | Aubert; Daniel (Plaisance Du Touch, FR), Ferrand; Claude (Ramonville Saint-Agne, FR), Maffrand; Jean-Pierre (Garonne, FR) |
| Assignee: | Sanofi, S.A. (Toulouse, FR) |
| Application Number: | 06/510,582 |
|
Patent Claim Types: see list of patent claims | Compound; Use; Composition; Dosage form; |
Drugs Protected by US Patent 4,529,596
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 4,529,596
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| France | 82 12599 | Jul 13, 1982 |
International Family Members for US Patent 4,529,596
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 25384 | ⤷ Try a Trial | |||
| Australia | 1663783 | ⤷ Try a Trial | |||
| Australia | 554358 | ⤷ Try a Trial | |||
| Canada | 1194875 | ⤷ Try a Trial | |||
| Czechoslovakia | 246062 | ⤷ Try a Trial | |||
| Czechoslovakia | 246082 | ⤷ Try a Trial | |||
| Czechoslovakia | 8305281 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
